SOURCE: Ken Research or prnewswire.com
GURUGRAM, India, March 15, 2018 /PRNewswire/ — Ken Research Logo (PRNewsFoto/Ken Research) Ken Research Logo (PRNewsFoto/Ken Research) The total number of public and private hospitals is likely to exceed 1,890 by 2022 as compared to over 1,530 in 2017 as investments in establishing healthcare facilities continues to witness an upward trend. Rising need for screening of infectious diseases and establishment of hospitals and clinics and up gradation of existing lab services to foster clinical laboratory market. Emphasis on providing quality healthcare services in rural areas and clinical test outsourcing to independent labs provides lucrative opportunities. The pharmaceutical market is anticipated to witness rise in demand for oncology and anti-infective drugs. Health supplements are expected to remain as the fastest growing therapeutic drug segment in the near future. Growing investment in public and private health care sector will drive the market for medical devices, with ophthalmic equipments, anesthesia instruments, dialysis equipments, endoscope equipments and medical furniture to register heightened demand. Vietnam healthcare market has shown healthy growth during 2012-2017 at a CAGR of 10.8% driven by rise in healthcare expenditure and incline in Universal Health Coverage (UHC) in the country. The UHC brought over 81.7% of the Vietnamese population under Health Insurance by 2017. Furthermore, rise in number of health care facilities and consumption of generic drugs aided in market growth during the last five years. (Logo: http://photos.prnewswire.com/prnh/20130909/638322 ) Vietnam Hospital market recorded growth at a CAGR of 7.8% during 2012-2017, driven by government’s investment in private health care sector and liberal foreign investment policies. Private clinics are known to be operating at only 50 to 60% of their capacity, or even as low as 20% in certain areas in Vietnam as compared to almost 120-160% bed occupancy rate in public hospitals. Major Private Hospitals in Vietnam included Vietnam France general Hospital, Hoan My Private General Hospital, Phu Tho Private General Hospital, Trien An Private General Hospital and Hong Ngoc Private General Hospital. Clinical laboratories market was driven by rise in incidence and prevalence of communicable and non-communicable disease in the country. The market witnessed a decline in growth during 2016 due to low hospital budget allocated towards laboratories and slow economic growth of the country; however, bounced back in 2017. During the period 2012-2017, clinical laboratory market grew at a CAGR of 12.2%. Public hospital labs are the largest segment in terms of volume of tests conducted as well as revenue. They are preferred due to high quality standards and cheaper associated cost. Medic Lab, VietLife and Hoan My were some of the largest independent clinic chains to be operating in Vietnam. The pharmaceutical market recorded growth at a CAGR of 14.4% during 2012-2017, driven by rise in self-medicating culture and OTC drug sales. About 90% of the active pharmaceutical ingredients (APIs) are imported by domestic companies. The country is increasingly turning towards use of locally produced generics. Sanofi, Hua Giang Pharmaceutical, GlaxoSmithKline, Traphaco, AstraZeneca, Pyempharco Novatis are some of the leading players in Vietnam Pharmaceutical Market. Number of domestic drug manufacturers is expected to rise to 230 by 2022. Nutritional and metabolism health supplements especially for skin care, anti-aging, eye health and digestive health was the largest selling therapeutic drug segment. The number of health supplement products recorded in the market was over 7,000, doubling from 2011. Foreign players are more active in non-herbal segment whereas domestic companies are better positioned in herbal supplement segment. About 90% of all medical devices sold in Vietnam were imported. Local producers are limited in number and have only been able to supply basic medical supplies such as consumables, hospital beds and rubber health products. The medical devices market recorded growth at a CAGR of 7.8% during the period 2012-2017 driven by liberal imports and surge in Orthopedic and Prosthetic medical equipments. Public hospitals, clinics and health centers were the largest purchasers of medical equipments and preferred advanced medical devices. According to the report by Ken Research titled “Vietnam Healthcare Market Outlook to 2022 – by Hospitals & Clinics, Clinical Laboratories, Pharmaceutical and Medical Device Segment”, rising public and private expenditure on healthcare facilities and increased emphasis on domestic production of generic drugs and medical devices will the overall market. Key Topics Covered in the Report: Vietnam Healthcare Market Size by Hospitals & Clinics, Clinical Laboratories, Pharmaceutical and Medical Device Vietnam Hospital Market Size Market Segmentation By Single and Multispecialty Hospitals By Public and Private Hospitals By Region By Outpatients and Inpatients Comparative Analysis of Major Hospitals in Vietnam Hoan My Group Phu Tho General Hospital Franco-Vietnamese Hospital Hanoi French Hospital Trien An Private General Hospital Hong Ngoc Private General Hospital Vietnam Hospitals Future Outlook and Projections by Revenue Vietnam Clinical Laboratory Market Size Vietnam Clinical Laboratory Market Segmentation By Type of Laboratory (Independent Clinical Lab, Hospital Labs and Physician Office Labs) By Public and Private Hospital Labs By Type of Tests (Lab test, X-ray, Ultrasound, CT Scan) Investment Model for Setting up a Diagnostic Laboratory Comparative Analysis of Major Independent Diagnostics Labs in Vietnam Medic Lab VietLife Hoan My Vietnam Clinical Laboratory Market Future Outlook and Projections By Type of Laboratory (Independent Clinical Lab, Hospital Labs and Physician Office Labs) Vietnam Pharmaceutical Market Size Vietnam Pharmaceutical Market Segmentation By Therapeutic Segments (Metabolism and Nutritional Medicine, Cardiovascular, CNS, System Infection, Oncology, Respiratory, Musculoskeletal and Others) By Generic and Patented Drug By OTC and Prescription Drugs Comparative Analysis of Major Players in Vietnam Pharmaceutical Market DHG Pharma Traphaco Pymepharco Ha Tay Pharmaceutical Mekophar Domesco Imexpharm OPC Pharmaceuticals Vietnam Pharmaceutical Market – Trade Scenario Vietnam Pharmaceutical Market Future Outlook and Projections By Therapeutic Segments (Metabolism and Nutritional Medicine, Cardiovascular, CNS, System Infection, Oncology, Respiratory, Musculoskeletal and Others) By Generic and Patent Drugs By OTC and Prescription Drugs Vietnam Medical Devices Market Size Vietnam Medical Devices Market Segmentation By Application (Orthopedic and Prosthetic Applications, Diagnostic Imaging Equipment, Paraclinical Equipment, Emergency Medical Equipment, Operation Room Equipment and Others) By Material (Textile Products, Electronic Products, Plastic Products, Rubber Products and Others) By Equipments (Consumables, Diagnostic Imaging, Dental Products, Orthopedic and prosthetics, Patient Aids and Others) By End User (Public hospitals, Local Private hospitals, Foreign Owned Hospitals and Medical Education, Research Institution and Others) Comparative Analysis of Major Players in Vietnam Medical Devices Market Major Domestic Companies Japan Vietnam Medical Danameco Armephaco Major Domestic Companies GE Healthcare, Vietnam Terumo BCT Philips, Vietnam Vietnam Medical Devices Market Future Outlook and Projections By Equipments (Consumables, Diagnostic Imaging, Dental Products, Orthopedic and prosthetics, Patient Aids and Others) Vietnam Healthcare Market Future Outlook and Projections For more information on the market research report, please refer to below link: https://www.kenresearch.com/healthcare/general-healthcare/vietnam-healthcare-market-report/142714-91.html Related Reports by Ken Research Vietnam Clinical Laboratory Market Outlook to 2022 – by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan)1. Executive Summary 2. Research Methodology 3. Healthcare Scenario 4. Government and Private Spending on Healthcare 5. Cross Comparison of Healthcare Sector of Vietnam with Other Asia Pacific Countries 6. Mergers, Acquisitions and Funding in Healthcare Sector 7. Vietnam Healthcare Market Size By Revenue, 2012-2017 8. Vietnam Hospitals and Clinics Market Size by Revenue/ Number of Hospitals/ Beds, 2012-2017 8.1. Vietnam Hospitals and Clinics Market Segmentation 8.1.1. By Single Specialty and Multispecialty Hospitals, 2017 8.1.2. By Public and Private Hospitals, 2017 8.1.3. By Region, 2017 8.2. Market Share of Major Hospitals and Clinics, 2017 8.3. Comparative Analysis of Major Hospitals and Clinics in Vietnam 8.4. Vietnam Hospitals and Clinics Market Future Outlook and Projections on the basis of Revenue, 2018-2022 8.4.1. By Public and Private Hospitals 8.4.2. By Single Specialty and Multispecialty Hospitals 9. Vietnam Diagnostic Laboratories Market 9.1. Vietnam Diagnostic Laboratories Market Overview 9.2. Vietnam Diagnostic Laboratories Market Size on the basis of Revenue, 2012-2017 9.3. Vietnam Diagnostic Laboratories Market Segmentation 9.3.1. By Imaging and Pathology Laboratories on the Basis of Number of Laboratories and Revenue, 2017 9.3.2. By Type of Tests on the Basis of Revenue, 2017 9.4. Investment Model for Setting up a Diagnostic Laboratory 9.5.Company Profile of Major Diagnostic Laboratory Chains in Vietnam, 2017 9.5.1. Medic Lab 9.5.2. VietLife 9.5.3. Hoan My 9.6. Comparative Analysis of Major Diagnostic Laboratories in Vietnam, 2017 9.7. Vietnam Diagnostic Lab Market Future Outlook and Projections 9.7.1. By Type of Test on the Basis of Revenue, 2018-2022 9.7.2. By Imaging and Pathology on the Basis of Revenue, 2018-2022 10. Vietnam Pharmaceutical Market Overview and Size by Revenue, 2012-2017 Growth Drivers Restraints 10.1. Vietnam Pharmaceutical Market Segmentation by Revenue, 2017 10.1.1. By Generic and Patented Drugs, 2017 10.1.2. By Therapeutic Drugs including Analgesic, Anti-inflammatory, Respiratory, Nutraceutical, Cardiovascular, Diabetes and Others, 2017 10.2. Government Regulations for Launch of New Drug How are Drugs Procured by Public Hospitals? 10.4. Comparative Analysis of Pharmaceutical Companies in Vietnam, 2017 10.5. Trade Scenario of Vietnam Pharmaceutical Market on the Basis Revenue, 2017 10.5.1. Import of Pharmaceutical Products 10.5.2. Export of Pharmaceutical Products 10.6. Market Share of Major Players in Pharmaceutical Market, 2017 Company Profile of Major Players DHG Pharma Traphaco Pymepharco Ha Tay Pharmaceutical Mekophar Domesco Imexpharm OPC Sanofi GSK AstraZeneca Novartis Roche Pfizer MSD Bayer 10.7. Vietnam Pharmaceutical Market Future Outlook and Projections on the basis of Revenue, 2018-2022 10.7.1. By Generic and Patented Drugs, 2022 10.7.2. By Therapeutic Drugs, 2022 11. Vietnam Medical Devices Market Overview and Size by Revenue, 2012-2017 11.1. Vietnam Medical Devices Market Segmentation by Revenue, 2017 11.1.1. By Type of Devices including list of top devices imported 11.1.1.1. Orthopedic and Prosthetic Applications 11.1.1.2. Diagnostic Imaging Equipment 11.1.1.3. Paraclinical Equipment 11.1.1.4. Emergency Medical Equipment 11.1.1.5. Medical Consumables 11.1.1.6. Dental Products 11.1.1.7. Patient Aids 11.1.1.8. Operation Room Equipment 11.2. Import of Medical Devices By Value / Volume and Destination 11.3. Company Profile of Top Medical Devices Companies in Vietnam Japan Vietnam Medical DANAMECO ARMEPHACO B Braun (Germany) Shimadzu (Japan) General Electric (US) Terumo BCT (Japan) Philips (Netherlands) 11.4. Vietnam Medical Devices Future Outlook and Projections on the basis of Revenue, 2018-2022 11.4.1. By Type of Devices, 2022 12. Role of IT Companies in Vietnam Healthcare Sector 13. Vietnam Healthcare Market Future Projections and Outlook, 2018-2022 14. Analyst Recommendations Disclaimer Contact Us
Note: We are not responsible for typo error, price change, substitute item, or available of item from online ads.
https://www.prnewswire.com/news-releases/vietnam-healthcare-market-on-the-basis-of-revenue-is-expected-to-reach-usd-18-billion-by-2022-ken-research-676921433.html]]>
